Digestive tract ultrasonic contrast agent applicable to patients with imbalance of intestinal flora

Abstract

The invention relates to a digestive tract contrast agent, and in particular to a digestive tract ultrasonic contrast agent applicable to patients with imbalance of intestinal flora. The ultrasonic contrast agent consists of the following components in parts by mass: 70-90 parts of barium sulfate and 15-30 parts of medicine extracts, wherein the medicine extracts include 8-10 parts of bifidobacterium, 8-10 parts of lactobacillus acidophilus, 8-10 parts of enterococcus faecalis, 1-2 parts of bacillus cereus, 5-7 parts of inulin, 5-7 parts of fructo-oligosaccharide, 5-7 parts of galactooligosaccharide, 5-7 parts of manoligosaccharide, 8-10 parts of rhizoma atractylodis macrocephalae, 5-7 parts of radix rehmanniae, 3-5 parts of rhizoma cimicifugae, 5-7 parts of honey, 5-7 parts of sesame oil,8-10 parts of bamboo juice, 5-7 parts of rhizoma coptidis, 3-5 parts of radix scutellariae, 5-7 parts of radix codonopsitis, 3-5 parts of radix ginseng, 5-7 parts of radix et rhizoma rhei, 3-5 partsof herba plantaginis, 5-7 parts of herba taraxaci, 5-7 parts of rhizoma bletillae and 3-5 parts of radix astragali. The contrast agent provided by the invention is safe and reliable in administration,and toxic and side effects as well as allergic reactions of chemical drugs can be prevented; the contrast agent can avoid injury to gastrointestinal mucosa intestinal flora while conducting contrast;and the contrast agent, after applied to the contrast, can be rapidly discharged, so that the in-vivo environment of a digestive tract can be kept at a normal level.

Description

technical field [0001] The invention relates to a digestive tract contrast agent, in particular to a digestive tract ultrasound contrast agent suitable for patients with intestinal flora imbalance. Background technique [0002] Contrast-enhanced ultrasound, also known as contrast-enhanced ultrasound, is a technology that uses contrast agents to enhance backscatter echoes and significantly improve the resolution, sensitivity, and specificity of ultrasound diagnosis. With the improvement of instrument performance and the emergence of new acoustic contrast agents, CEUS can effectively enhance the two-dimensional ultrasound images and blood Doppler signals of myocardial, liver, kidney, brain and other solid organs, reflecting and observing normal tissues and lesions. The blood perfusion of tissue has become a very important and promising development direction of ultrasonic diagnosis. Some people regard it as the third revolution after two-dimensional ultrasound, Doppler and col...

AI Technical Summary

Problems solved by technology

[0006] The technical problem solved by the present invention is that barium sulfate is not easy to be discharged during ultrasound contrast-enhanced gastrointestinal tract, and it must be discharged by taking laxatives or Kaisailu when necessary. Unhealthy digestive tract brings more adverse effects